Back

Clinical relevance of atrial fibrillation in patients with dilated cardiomyopathy hospitalized with acute heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - comorbidities 2 Comorbidities HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Nagy Eszter

Clinical County Hospital Targu Mures, Targu Mures (Romania)

5 More presentations in this session

Presentation thumbnail
Impact of anemia on the evolution of hospitalized HFpEF patients
Associate Professor A. Vintila (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Using a pragmatic health informatics approach to improve clinical care in people with diabetes and heart failure
Miss C. Doherty (London, GB)
Abstract Slides Video
Presentation thumbnail
HFWM: iron deficiency in worsening heart failure is associated with a transcriptional profile of heme-sparing and reduced immune response processes
Doctor N. Grote Beverborg (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Pancreatic enzymes increase in acute heart failure
Miss M. Vijver (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Association of albuminuria with NYHA functional class in outpatients with advanced heart failure
Doctor C. Lucena Montenegro (Recife, BR)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - comorbidities 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Inflammation and arterial hypertension are the main risk factors occurrence of AF in patients with heart failure patients with preserved ejection fraction (retrospective study)
thumbnail
Congress Presentation
The effect of gender on prognosis in patients with sinus rhythm and in patients with atrial fibrillation in heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources